Twelve metabolites of the synthetic cannabinoid, EAM-2201, had been tentatively identified in human hepatocytes in vitro, As well as in human liver and urine specimens in vivo for the first time. In vitro outcomes point out that AM-2201 has to be examined for likely pharmacokinetic drug interactions in vivo as https://hemalchem.com/product-category/am-series/